[Jiayuan Announces Third Quarter 2012 Financial Results BEIJING, Nov.20, 2012 /PRNewswire-FirstCall/ Jiayuan.com International (Jiayuan) (DATE), operator of the largest onlineting platform in China, today announced its unaudited financial results for the third quarter ended September30, 2012. Third Quarter 2012 Highlights (1) Net revenues for the third quarter 2012 were RMB113.5 million (US$18.1 million), a year-over-yearrease]
[CHARM COMMUNICATIONS INC. Legend Town, CN01 Floor 4 No.1 Ba Li Zhuang Dong Li, Chaoyang District Beijing 100025, PRC November 23, 2012 VIA EDGAR AND FACSIMILE Mr. Larry Spirgel Assistant Director 100 F Street, N.E. RE: Charm Communications Inc. Form 20-F for the Fiscal Year Ended December 31, 2011 Filed April 27, 2012 Form 6-K filed August 24, 2012 File]
[Jiayuan Announces Third Quarter 2012 Financial Results BEIJING, Nov.20, 2012 /PRNewswire-FirstCall/ Jiayuan.com International (Jiayuan) (DATE), operator of the largest onlineting platform in China, today announced its unaudited financial results for the third quarter ended September30, 2012. Third Quarter 2012 Highlights (1) Net revenues for the third quarter 2012 were RMB113.5 million (US$18.1 million), a year-over-yearrease]
[ReneSola to Report Third Quarter 2012 Results on November 30, 2012 Company Updates Third Quarter and Full Year 2012 Outlook JIASHAN, China, November 21, 2012 Based on preliminary data, the Company provides the following updates to its outlook: · For the third quarter of 2012, the Company estimates its total solar wafer and module shipments to be in its previously] []
[ReneSola to Report Third Quarter 2012 Results on November 30, 2012 Company Updates Third Quarter and Full Year 2012 Outlook JIASHAN, China, November 21, 2012 Based on preliminary data, the Company provides the following updates to its outlook: · For the third quarter of 2012, the Company estimates its total solar wafer and module shipments to be in its previously] []
[TPI Reports First Quarter Fiscal Year 2013 Financial Results CHENGDU, China, Nov. 15, 2012 -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for first quarter of the fiscal year 2013. First Quarter of Fiscal Year 2013 Ended] [Tianyin Pharmaceutical Co., Inc. (“TPI”) First Quarter of Fiscal Year 2013 Earnings Call November 15, 2012 8:30 AM ET Operator James Tong TPI First quarter of fiscal year 2013 ended September 30, 2012, financial highlights: revenue was $16 million compared with $17.5 million in first quarter of fiscal year 2012 (“FIQ 2012”). Operating income was $2.2 million compared with $2.1] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT November 15, 2012 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]
[TPI Reports First Quarter Fiscal Year 2013 Financial Results CHENGDU, China, Nov. 15, 2012 -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for first quarter of the fiscal year 2013. First Quarter of Fiscal Year 2013 Ended] [Tianyin Pharmaceutical Co., Inc. (“TPI”) First Quarter of Fiscal Year 2013 Earnings Call November 15, 2012 8:30 AM ET Operator James Tong TPI First quarter of fiscal year 2013 ended September 30, 2012, financial highlights: revenue was $16 million compared with $17.5 million in first quarter of fiscal year 2012 (“FIQ 2012”). Operating income was $2.2 million compared with $2.1] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT November 15, 2012 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]
[China Southern Airlines Company Limited Xie Bing and Liu Wei By order of the Board Joint Company Secretaries Guangzhou, the People’s Republic of China 23 November 2012 As at the date of this announcement, the Directors include Si Xian Min, Wang Quan Hua and Yuan Xin An as non-executive Directors, Tan Wan Geng, Zhang Zi Fang, Xu Jie Bo and] []
[Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho Senior Vice President & Chief Financial Officer]
[China Southern Airlines Company Limited Xie Bing and Liu Wei By order of the Board Joint Company Secretaries Guangzhou, the People’s Republic of China 23 November 2012 As at the date of this announcement, the Directors include Si Xian Min, Wang Quan Hua and Yuan Xin An as non-executive Directors, Tan Wan Geng, Zhang Zi Fang, Xu Jie Bo and] []
